University of Helsinki Doctoral Position in Systems Biology of Drug Resistance 2017, Finland

Publish Date: Jan 09, 2017

Deadline: Feb 01, 2017


Research Programs Unit (RPU) of the Faculty of Medicine at the University of Helsinki is a top-quality research environment. The research programs operate at the Meilahti Campus, the Academic Medical Center Helsinki, where the close vicinity of the research laboratories with Helsinki University Hospital and Finnish Institute for Molecular Medicine supports the integration of biomedical, translational, and clinical research.

Systems biology of drug resistance in cancer research group in the Research Program Units, Faculty of Medicine is seeking outstanding candidates for


The open position is in the fields of systems biology and translational cancer research in projects funded by EU Horizon 2020 (HERCULES) and Academy of Finland (OVCURE). The goal of the HERCULES project is to use cutting-edge single-cell measurement technologies and computational methods to identify drug resistant cell populations and develop combinatorial treatments to effectively kill drug resistant cancer cells. The goal of the OVCURE project is to develop and apply integrative computational methods to identify predictive models for treatment efficacy by taking an advantage of multi-level big data (e.g., transcriptomics, genomics, genetics, epigenetics, and proteomics jointly with clinical and functional information). Both projects are based on prospective ovarian cancer patient clinical samples taken before and after the treatment.

We are looking for an ambitious graduate student with strong enthusiasm towards science. A successful candidate has a strong background in applied mathematics, machine learning, multivariate statistics, computer science, programming or bioinformatics, and a completed or soon to be completed Master’s degree. Basic understanding of cancer biology or genetics/genomics is considered as an asset and ability to work together with medically/biologically oriented researchers is required.

Initial contract of employment will be done for a minimum of two years and the starting date is to be agreed, preferably in spring 2017. A trial period of four months will be applied. Salary will be based on the Universities salary scheme for teaching and research personnel composed of both task specific and personal performance components.

We offer an international multidisciplinary research environment with state-of-the-art facilities. The research will be carried out in the Systems biology of drug resistance in cancer research group in collaboration with highly skilled groups with complementary expertise in biochemistry, molecular biology, high-throughput molecular technologies, mathematical and computational modelling, and clinics.

To apply, please submit your application by February 1st, 2017 using the University of Helsinki electronic recruitment system by clicking on Apply for job. Internal applicants (i.e., current employees of the University of Helsinki) must submit their applications through the SAP HR portal.

Include your application letter, CV, publication list and names of two references as one pdf attachment in the application. For further information contact: Sampsa Hautaniemi,, Tel. +358 50 336 4765.

For more information click "Further official information" below.

This opportunity has expired. It was originally published here:

Similar Opportunities



Study Levels


Opportunity Types


Eligible Countries


Host Countries